EU to retain antidumping duty on US ethanolamine exports

Published: 3-Feb-2010
Ingredients Regulatory

The EU is expected to restore an antidumping duty on US exports of ethanolamines, a key pharmaceutical ingredient.


The EU is expected to restore an antidumping duty on US exports of ethanolamines, a key pharmaceutical ingredient. A protective tariff was introduced in 1994 because of concerns that US exporters were dumping cut-priced ethanolamines on European markets.

Authorisation for this duty is about to expire, and the European Commission has recommended that it be re-approved for another four years. Major US producers would be caught by the tariff: the Dow Chemical Corporation would pay Euro 59.25/tonne; INEOS Americas €69.40/tonne; and Huntsman €111.25/tonne, the duty level that would apply to all other US producers.


  • Companies:
  • Dow Chemical Company
See more

You may also like

Ingredients

Dow to increase capacity for solid CARBOWAX SENTRY polyethylene glycols to meet global demand

Read more
Dow, a leading supplier of polyethylene glycols (PEGs), today announced a low-capital, high-ROIC investment in a new congealer to increase its production capacity for CARBOWAX SENTRY polyethylene glycols in solid powder and granular form

Trending Articles

  1. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  2. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena
  3. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  4. The evolution of the pharma industry: From reactive to disruptive Globally, the pharma industry has witnessed waves of changes during the last century; we have evolved, writes Ajit Kanetkar, Head, Process Technology, ACG, from maintaining a conservative outlook and being solely reactive to disease and healthcare issues to having a radical and disruptive approach
  5. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Ingredients

Dow to increase capacity for solid CARBOWAX SENTRY polyethylene glycols to meet global demand

Dow, a leading supplier of polyethylene glycols (PEGs), today announced a low-capital, high-ROIC investment in a new congealer to increase its production capacity for CARBOWAX SENTRY polyethylene glycols in solid powder and granular form
Ingredients

Dow and Colorcon broaden the scope of their Controlled Release Alliance

From January next year the partnership will include Dow's advanced technology based excipients
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Ingredients see a drive for more science

The need for greater solubility and bioavailability of new medicines, as well as increasing manufacturing efficiencies are driving developments in ingredients. Susan Birks reports on the latest trends
Ingredients

CPHI: Dow introduces solvent-free technology for coating barrier membranes

Ethocel HP enables faster tablet coating times, increasing drug production productivity yields
Ingredients

LIVE FROM CPHI: Dow Pharma & Food and Colorcon to have commercial availability of Methocel DC2 by year end

Offers improved process control for matrix tablet production
You need to be a subscriber to read this article.
Click here to find out more.
Media

Good growth for ingredients, but costs could rise

In the fast growing API and excipient markets, solubility, taste-masking and functionality are the focus. Susan Birks looks at current trends and issues on the horizon
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Improving the taste of paediatric medicines

Ion exchange excipients are well characterised and have a favourable safety profile in oral formulations. Amie Gehris and Jon Fisher, Dow Chemical Co, look at their use in overcoming formulation challenges for oral paediatric medications
Subscribe now